drugset / Trial / NCT05543694

ED90 of Epidural Bupivacaine With Lidocaine for the Initiation of Labor Analgesia

NCT05543694 ↗

Phase 4 Recruiting 120 enrolled Brigham and Women's Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor after receiving a lidocaine "test dose"

Timeline

Start
2022-10-01
Primary completion
2027-06-30
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 20 mg Other
Subject Bupivacaine Other / unclassified 25 mg Other
Subject Bupivacaine Other / unclassified 40 mg Other

Indications

No indication recorded.